For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
The Omicron journey, a stark warning from inside out
+Opinion
The Omicron journey, a stark warning from inside out
Friday 1 April 2022, 11:40 AM

There was no doubting the day 0 test result
Terry Taylor is president of the New Zealand Institute of Medical Laboratory Science. He recently fell victim to COVID-19
This is a real-time assessment of living and breathing through Omicron. We are constantly told Omicron is a mild illness, nothing to worry about, most
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.